Skip to main content

Table 2 Underlying cardiac conditions and underlying heart diseases

From: Clinical impact of applying strategic programming in patients with implantable cardioverter-defibrillators beyond reducing inappropriate shocks

 

Group A

Group B

Structurally normal

45

24

 Brugada syndrome

7

5

 Idiopathic VF

32

19

 Long QT syndrome

5

1

 Variant angina

1

0

Structurally abnormal but normal LV systolic function

  

 Amyloidosis

2

0

 ARVC

6

1

 Myotonic dystrophy

0

1

 Sarcoidosis

1

1

 HCMP

10

6

Structurally abnormal and reduced LV systolic function

  

 DCMP

20

16

 ICMP

10

12

  1. ARVC arrhythmogenic right ventricular cardiomyopathy, DCMP dilated cardiomyopathy, HCMP hypertrophic cardiomyopathy, ICMP ischemic cardiomyopathy, VF ventricular fibrillation